Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K241595
    Date Cleared
    2025-02-27

    (269 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Veol Medical Technologies Pvt Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    EzVu Visual Vasopressor Injector (EV-19) is intended to inject vasopressor solution into the uterine musculature during laparoscopic surgery.

    Device Description

    EzVu Visual Vasopressor Injector (EV-19) is a 330 mm long and 5 mm diameter hollow bore laparoscopic instrument, used to enable laparoscopic flashback visualization before injecting Vasopressor drug into the uterine musculature during laparoscopic surgery. It consists of a stainless steel needle at the distal end, securely connected to a hub, an elongated shaft with transparent window at the distal end and stopcock with luer connection at the proximal end onto which a syringe can be attached. The shaft is made of transparent plastic tube, surrounded by a stainless steel tube along the proximal portion of the injector to provide stability. The stainless steel tube around the transparent plastic tube is wrapped in a heat shrink. The injector is available in one needle size (19 gauge).

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study details for the EzVu Visual Vasopressor Injector (EV-19), based on the provided FDA 510(k) summary:

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance Criteria (Primary Endpoints)Reported Device Performance
    Blood Stain should be clearly visible in the transparent window when aspirated.Blood aspirate was detected in 4 out of 25 cases (16% of aspirations). The document states "Blood Stain should be clearly visible... when aspirated," but doesn't explicitly state the percentage of times it was clearly visible when present, only how often aspiration occurred and blood was observed.
    No leakage or breakage should be observed in any samples of the EzVu device.The device maintained structural integrity throughout the study. No leakage or breakage was reported.

    Secondary Endpoint:

    Acceptance Criteria (Secondary Endpoint)Reported Device Performance
    The performance of EzVu and other laparoscopic instruments should not be affected when used together in the procedure.Compatibility with laparoscopic instruments was confirmed. All surgeons provided usability ratings of 4.6 or greater (on a 1-5 Likert scale) for 19 usability questions, indicating favorable device usability.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size:
      • Clinical Study (Patients): 13 women
      • Injections: 24 injections across the 13 patients.
      • Blood Aspiration Cases: 25 cases (Note: this number is slightly different from the 24 injections mentioned earlier in the text for detection of blood aspirate).
    • Data Provenance: The study was a "multi-center, prospective observational study." The country of origin is not explicitly stated, but the sponsor is located in Navi Mumbai, Maharashtra, India.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    • Number of Experts: 5
    • Qualifications: "trained laparoscopic gynecological surgeons"

    4. Adjudication Method for the Test Set

    The document does not explicitly describe an adjudication method for the clinical study's primary and secondary endpoints. It appears that the observations (visibility of blood aspirate, leakage/breakage, compatibility, and usability ratings) were collected directly from the surgical procedures and surgeon feedback.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    There is no indication that a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was done, nor is there any mention of AI assistance or its effect size on human readers. This device is a physical injector, not an AI-powered diagnostic tool.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This question is not applicable. The EzVu Visual Vasopressor Injector is a physical medical device, not an algorithm, and does not operate without human interaction. Its performance is intrinsically linked to its use by a surgeon.

    7. The Type of Ground Truth Used

    The ground truth for the clinical study was established through direct observation during surgical procedures by trained laparoscopic gynecological surgeons and their subjective feedback via Likert scales for usability. For the primary endpoint, it was the actual presence/absence of blood aspirate and device integrity as observed by the surgeon, and for the secondary endpoint, it was the surgeons' qualitative assessment of performance and compatibility.

    8. The Sample Size for the Training Set

    The document does not mention a training set, as this is a physical medical device and not an AI/machine learning algorithm that requires a training phase. The described studies are for validation of the fully developed device.

    9. How the Ground Truth for the Training Set was Established

    This question is not applicable, as there is no mention of a training set for this device.

    Ask a Question

    Ask a specific question about this device

    K Number
    K240205
    Date Cleared
    2024-04-15

    (81 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Veol Medical Technologies Pvt Ltd.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The device is indicated for use as a receptacle for the collection of tissue, organs and calculi during general and laparoscopic procedures.

    Device Description

    The EzCatch Tissue Retrieval Bag consists of a long cylindrical tube (Deployer Handpiece) and a polyurethane bag (Tissue Retrieval Bag) that minimizes spillage and intraoperative contamination by isolating and containing specimens. This device is designed for introduction and use through all appropriately sized trocar sleeve (of generally 10mm size). The EzCatch Tissue Retrieval Bag has application for safe, convenient removal of tissue specimens such as the appendix, an ectopic pregnancy, gallbladder, gallstones, lymph nodes, ovaries, small sections of bowel and other tissue structures.

    AI/ML Overview

    The medical device in question is the Ez Catch Auto, Ez Catch YR, and Ez Catch TR, which are tissue retrieval bags indicated for use as a receptacle for the collection of tissue, organs, and calculi during general and laparoscopic procedures.

    Acceptance Criteria and Device Performance:

    The document does not explicitly state acceptance criteria in a table format with corresponding reported device performance metrics for the tested parameters. However, it lists several non-clinical tests performed, implying that the device successfully met the internal criteria for these tests to support a claim of substantial equivalence.

    Based on the information provided, here's a table summarizing the tests performed, which indirectly represent areas where the device needed to perform acceptably:

    Test/Criteria CategoryReported Device Performance (Implied by successful testing)
    Leak TestMet internal specifications for leak integrity
    Force to push out retracted bag testMet internal specifications for deployment force
    Force to withdraw retracted bag testMet internal specifications for retraction force
    Penetration force testMet internal specifications for resistance to penetration
    Tightening Line Tensile Strength TestMet internal specifications for tensile strength
    Retracted Bag Peeling Force TestMet internal specifications for peeling force
    Sterilization validationSuccessfully validated for sterilization effectiveness
    EO, ECH residuesLevels within acceptable limits
    Shelf Life testingDemonstrated acceptable shelf life
    Biocompatibility testing (ISO 10993-1)Met biocompatibility standards

    Study Information:

    The document describes a series of non-clinical tests conducted on the subject device to demonstrate its performance and safety, and to support its substantial equivalence to a predicate device (K201243 - Disposable Specimen Retrieval Bag).

    1. Sample sizes used for the test set and the data provenance:
      The document does not explicitly state the specific sample sizes used for each of the non-clinical tests (e.g., number of bags tested for the leak test). It only states that "non-clinical tests were performed in the subject device." The data provenance is implied to be from internal testing conducted by the manufacturer, Veol Medical Technologies Pvt Ltd, given the submission is for their device. The tests are "retrospective" in the sense that they were conducted for regulatory submission, not as a prospective clinical trial.

    2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
      This information is not applicable to the non-clinical tests described. Ground truth and expert consensus are typically associated with clinical studies involving human interpretation or pathology, which are not outlined here. The "ground truth" for non-clinical tests would be the established engineering specifications and regulatory standards (e.g., ISO 10993-1).

    3. Adjudication method for the test set:
      Not applicable. Adjudication methods like 2+1 or 3+1 refer to independent review of cases, typically in clinical studies, to establish ground truth or resolve discrepancies in interpretations. For non-clinical tests, performance is measured against predefined, objective specifications.

    4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
      Not applicable. The document describes a medical device (tissue retrieval bag), not an AI-powered diagnostic or assistive tool. Therefore, an MRMC study related to AI assistance is irrelevant to this submission.

    5. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
      Not applicable, as this is not an AI/algorithm-based device.

    6. The type of ground truth used:
      For the non-clinical tests, the "ground truth" is defined by established engineering specifications, performance standards, and regulatory requirements (e.g., ISO 10993-1 for biocompatibility). The success of the tests indicates that the device met these objective criteria.

    7. The sample size for the training set:
      Not applicable. This is a medical device, not a machine learning model, so there is no concept of a "training set."

    8. How the ground truth for the training set was established:
      Not applicable, as there is no training set for this device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1